InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Thursday, 04/06/2023 1:21:49 AM

Thursday, April 06, 2023 1:21:49 AM

Post# of 16696
Follow up: Miraculins Inc.

"The board recognizes and appreciates James Kinley's contributions and dedication in his role as CFO over the past four years and we wish him well in the future," said Harry Bloomfield, Chairman of the Miraculins board.

https://www.accesswire.com/435700/Miraculins-Announces-the-Appointment-of-Chris-Carmichael-as-Chief-Financial-Officer

Muraculincs changes to Luminor Medical Technologies.

https://www.newsfilecorp.com/release/33402/Luminor-Medical-Technologies-Changes-Its-Name-to-RISE-Life-Science-Corp.

Luminor Medical Technologies Changes Its Name to RISE Life Science Corp.

"Mr. Bloomfield's insights during his tenure as Chairman, helped to significantly move the company forward." said Anton Mattadeen. "We wish to thank him for his leadership."

Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.

https://www.newswire.ca/news-releases/britannia-completes-go-public-transaction-via-reverse-takeover-of-rise-life-sciences-and-launches-britannia-life-sciences-inc--890705573.html

Miraculins to Luminor to Rise to Britannia

Full Stop

Algernon Pharmaceuticals Announces Appointment of Harry Bloomfield, QC. as a New Board Director and Chairman

September 9, 2021

“The Company welcomes Harry Bloomfield as its newest Board member and Chairman,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “His extensive background and years of experience in senior business roles will be a tremendous asset to the Company as it moves forward executing its exciting and unique drug repurposing business plan.”

https://finance.yahoo.com/news/algernon-pharmaceuticals-announces-appointment-harry-110000362.html

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has appointed James Kinley as its chief financial officer, effective December 1, 2021.

Kinley will report to CEO Christopher Moreau, according to a statement.

"James Kinley brings significant functional expertise and technical knowledge to the company in all aspects of corporate finance, financial planning and accounting,” said Moreau.

https://www.proactiveinvestors.com/companies/news/967761/algernon-pharmaceuticals-appoints-former-medicure-financial-chief-james-kinley-as-cfo-967761.html

Leadership @ Algernon Pharmaceuticals Inc.

Harry Bloomfield, Board of Directors, Chairman

Christopher J. Moreau, CEO

James Kinley, CFO


Three Headed Monster In Black & White



The Devil Is In The Details...

And It's Headed For The Trips (.0001)

Hav @ it

M$